Nutritional assessment priorities by user profile

Nutritional risk varies substantially between GLP-1 users. Select the profile that best matches your situation. Priority tiers indicate where assessment should focus first. Supplementation should follow individual assessment, not replace it.

Prioritise assessment

Strongest evidence basis or highest risk for this profile. Assess at baseline or early in treatment.

Monitor and consider

Plausible risk with moderate indirect evidence. Monitor during treatment; supplement only if assessment confirms need.

Worth considering

Mechanistically plausible, lower urgency. Dietary review is appropriate; supplementation is low-risk at standard doses.

These profiles are educational frameworks based on mechanistic rationale and evidence from comparable populations. Prospective trial evidence in GLP-1 users is limited for most micronutrients. Priority tiers indicate where assessment should focus, not where supplementation should automatically begin. Individual review with a clinician or registered dietitian is recommended before starting any supplementation programme. Where evidence tags are shown on individual cards, they reflect evidence quality for that specific claim, which may differ from the general evidence base for that nutrient.